NEPHROLOGY & ENDOCRINE ASSOCIATES INC
1294 S JONES BLVD, LAS VEGAS, NV 89146
NPI Number
1801886700
Practice location · View on Google Maps
SOS Verification: Pending Review
Multiple SOS Matches
Total Medicaid Payments
$11,599,848
+1709% vs specialty average
Patients Seen
106,506
Total Claims
238,104
$ Per Patient
$109
Specialty avg: $122
Specialty Rank
#1 of 44
Internal Medicine, Nephrology providers in Nevada
Peer Average
$641,404
Average total for Internal Medicine, Nephrology
Claims per Patient
2.2
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $967,359 | |
| 2019 | $1,634,559 | |
| 2020 | $1,699,045 | |
| 2021 | $2,022,367 | |
| 2022 | $2,024,082 | |
| 2023 | $2,200,206 | |
| 2024 | $1,052,230 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 99233 | Hospital care — daily check by your doctor (complex update) | 123,693 | $7,253,340 | 62.5% | $59 |
| 99232 | Hospital care — daily check by your doctor (moderate update) | 77,104 | $2,675,110 | 23.1% | $35 |
| 99223 | Hospital admission — first day, complex or serious problem | 3,927 | $489,954 | 4.2% | $125 |
| 90935 | Dialysis — single treatment to clean the blood when kidneys don't work | 15,097 | $396,726 | 3.4% | $26 |
| 90960 | End-stage kidney disease monthly care — for patients 20 and older, 4+ visits | 4,495 | $370,767 | 3.2% | $82 |
| 99214 | Office visit for a moderate problem (established patient) | 4,070 | $174,882 | 1.5% | $43 |
| 99215 | Office visit for a complex or serious problem (established patient) | 3,775 | $135,466 | 1.2% | $36 |
| 99255 | Medical service or procedure | 209 | $35,444 | 0.3% | $170 |
| 90961 | End-stage kidney disease monthly care — for patients 20 and older, 2-3 visits | 663 | $24,252 | 0.2% | $37 |
| 99213 | Office visit for a simple problem (established patient) | 358 | $11,560 | 0.1% | $32 |
| 90966 | End-stage kidney disease monthly care — for patients 20+, home dialysis | 178 | $11,463 | 0.1% | $64 |
| 36902 | Artery and vein surgery | 120 | $7,410 | 0.1% | $62 |
| 99291 | Critical care — intensive treatment for a life-threatening condition (first 30-74 minutes) | 31 | $4,678 | 0.0% | $151 |
| 99222 | Hospital admission — first day, moderate to serious problem | 47 | $3,973 | 0.0% | $85 |
| 99231 | Hospital care — daily check by your doctor (minor update) | 106 | $1,877 | 0.0% | $18 |
| 75710 | Heart and blood vessel imaging | 37 | $1,230 | 0.0% | $33 |
| 99204 | New patient office visit — detailed visit for a serious problem | 15 | $962 | 0.0% | $64 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care se... | 224 | $471 | 0.0% | $2 |
| G9500 | Radiation exposure indices documented in final report for procedure using fluoroscopy | 1,183 | $207 | 0.0% | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 591 | $37 | 0.0% | $0 |
| 90970 | End-stage kidney disease home dialysis monthly care — ages 20+ | 15 | $27 | 0.0% | $2 |
| J2250 | Injection of midazolam (sedation medicine for procedures) | 191 | $11 | 0.0% | $0 |
| J3010 | Injection of fentanyl (strong pain medicine) | 168 | $2 | 0.0% | $0 |
| 6045F | Medical service or procedure | 37 | $0 | 0.0% | $0 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 1,770 | $0 | 0.0% | $0 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.